Showing results (21-30 of 195) with videos related to
Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Cardiovascular benefits of exogenous insulinAjay Chaudhuri, Paresh Dandona, Vivian FonsecaCurrent Atherosclerosis Reports|February 3, 2005
The impact of antidiabetic therapies on cardiovascular diseaseBrandy Panunti, Biju Kunhiraman, Vivian FonsecaExpert Review of Clinical Pharmacology|December 7, 2011
Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?Yehuda Handelsman, Vivian Fonseca, Julio RosenstockDiabetes/Metabolism Research and Reviews|December 25, 2004
Metabolic memory in diabetes--focus on insulinDerek LeRoith, Vivian Fonseca, Aaron VinikClinical Pharmacology and Therapeutics|November 21, 2018
A Model-Based Meta-Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic DosesAlan Maloney, Julio Rosenstock, Vivian FonsecaJournal of the Cardiometabolic Syndrome|May 6, 2008
Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factorsGeorge Bakris, Vivian Fonseca, JoAnne FoodyJournal of Diabetes and Its Complications|April 10, 2021
Economic burden of diabetes-related hypoglycemia on patients, payors, and employersLizheng Shi, Vivian Fonseca, Belinda ChildsDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetesCyrus V Desouza, Lindsey Rentschler, Vivian FonsecaJournal of Diabetes and Its Complications|October 6, 2022
Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: A focus on the BRAVO modelHui Shao, Lizheng Shi, Yilu Lin, et al.Clinical Chemistry|November 25, 2010
Therapeutic approaches to target inflammation in type 2 diabetesAllison B Goldfine, Vivian Fonseca, Steven E ShoelsonPageof 20